WO2000050083A1 - Agents facilitant l'absorption enterale - Google Patents
Agents facilitant l'absorption enterale Download PDFInfo
- Publication number
- WO2000050083A1 WO2000050083A1 PCT/JP2000/001090 JP0001090W WO0050083A1 WO 2000050083 A1 WO2000050083 A1 WO 2000050083A1 JP 0001090 W JP0001090 W JP 0001090W WO 0050083 A1 WO0050083 A1 WO 0050083A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- large intestine
- absorption
- absorption enhancer
- sodium
- medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002364780A CA2364780A1 (en) | 1999-02-26 | 2000-02-25 | Enteral sorbefacients |
US09/913,761 US6620788B1 (en) | 1999-02-26 | 2000-02-25 | Enteral sorbefacients |
EP00905337A EP1155701A4 (en) | 1999-02-26 | 2000-02-25 | AGENTS TO FACILITATE ENTERAL ABSORPTION |
AU26922/00A AU2692200A (en) | 1999-02-26 | 2000-02-25 | Enteral sorbefacients |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11050970A JP2000247911A (ja) | 1999-02-26 | 1999-02-26 | 大腸用吸収促進剤 |
JP11/50970 | 1999-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000050083A1 true WO2000050083A1 (fr) | 2000-08-31 |
Family
ID=12873683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2000/001090 WO2000050083A1 (fr) | 1999-02-26 | 2000-02-25 | Agents facilitant l'absorption enterale |
Country Status (7)
Country | Link |
---|---|
US (1) | US6620788B1 (ja) |
EP (1) | EP1155701A4 (ja) |
JP (1) | JP2000247911A (ja) |
AU (1) | AU2692200A (ja) |
CA (1) | CA2364780A1 (ja) |
TW (1) | TWI232754B (ja) |
WO (1) | WO2000050083A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2665464T3 (es) * | 2003-03-28 | 2018-04-25 | Sigmoid Pharma Limited | Forma de dosificación oral sólida que contiene microcápsulas sin costuras |
PT2079456E (pt) | 2007-04-04 | 2013-03-13 | Sigmoid Pharma Ltd | Composições farmacêuticas de ciclosporina |
WO2008132707A1 (en) | 2007-04-26 | 2008-11-06 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
US20130165508A1 (en) * | 2007-09-13 | 2013-06-27 | Robert C. Stover | Methods and formulations for treating ineffective or decreased esophagal motility |
BRPI1012196B1 (pt) | 2009-05-18 | 2021-11-30 | Sublimity Therapeutics Limited | Composição compreendendo gotas de óleo |
GB2485327A (en) | 2009-08-12 | 2012-05-09 | Sigmoid Pharma Ltd | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
CA2849448C (en) * | 2011-09-06 | 2020-03-24 | Bing Lou Wong | Oral delivery for hemoglobin based oxygen carriers |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
CN107106644B (zh) | 2014-11-07 | 2022-04-15 | 卓越治疗有限公司 | 包含环孢菌素的组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0667148A1 (en) * | 1992-11-06 | 1995-08-16 | Hisamitsu Pharmaceutical Co., Inc. | Peroral pharmaceutical preparation releasable in lower digestive tract |
WO1998005310A1 (fr) * | 1996-08-02 | 1998-02-12 | Hisamitsu Pharmaceutical Co., Inc. | Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4297621A (en) | 1980-10-02 | 1981-10-27 | Sperry Corporation | Cathode ray tube beam deflection amplifier system |
ZA825384B (en) | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
US4476116A (en) | 1982-12-10 | 1984-10-09 | Syntex (U.S.A.) Inc. | Polypeptides/chelating agent nasal compositions having enhanced peptide absorption |
AU572815B2 (en) | 1982-12-29 | 1988-05-19 | Armour Pharmaceutical Company | Pharmaceutical calcitonin compositions for intranasal application |
NZ211078A (en) * | 1984-03-19 | 1987-08-31 | Bristol Myers Co | Oral dosage form of etoposide |
IL77186A0 (en) | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
JPH0643390B2 (ja) | 1986-04-08 | 1994-06-08 | 久光製薬株式会社 | アザシクロアルカン誘導体 |
JPH0242027A (ja) | 1988-08-02 | 1990-02-13 | Minofuaagen Seiyaku Honpo:Goushi | 経粘膜吸収促進剤及びこれを用いた経鼻投与剤 |
IT1230576B (it) | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
JPH078806B2 (ja) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | カルシトニン類含有経鼻投与用乳剤 |
GB9020544D0 (en) | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
JP3090353B2 (ja) | 1991-09-17 | 2000-09-18 | 旭化成工業株式会社 | パラチロイドホルモン類含有経鼻投与用乳剤 |
JPH0643390A (ja) | 1992-06-19 | 1994-02-18 | Nec Corp | 印刷照合装置 |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
JPH0913286A (ja) | 1995-06-23 | 1997-01-14 | Kimoto & Co Ltd | マーキングシートおよびこれを用いる多色マークの作製方法 |
JP3185206B2 (ja) | 1995-07-20 | 2001-07-09 | 田辺製薬株式会社 | 消化管下部放出型被覆カプセル製剤 |
SG80553A1 (en) | 1995-07-20 | 2001-05-22 | Tanabe Seiyaku Co | Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract |
JPH10152431A (ja) | 1996-08-02 | 1998-06-09 | Hisamitsu Pharmaceut Co Inc | 経口製剤用カプセルと経口カプセル製剤 |
EP0919288A3 (en) | 1997-11-25 | 2003-10-08 | Nordson Corporation | Electrostatic dispensing apparatus and method |
-
1999
- 1999-02-26 JP JP11050970A patent/JP2000247911A/ja active Pending
-
2000
- 2000-02-23 TW TW089103115A patent/TWI232754B/zh not_active IP Right Cessation
- 2000-02-25 AU AU26922/00A patent/AU2692200A/en not_active Abandoned
- 2000-02-25 CA CA002364780A patent/CA2364780A1/en not_active Abandoned
- 2000-02-25 US US09/913,761 patent/US6620788B1/en not_active Expired - Fee Related
- 2000-02-25 EP EP00905337A patent/EP1155701A4/en not_active Withdrawn
- 2000-02-25 WO PCT/JP2000/001090 patent/WO2000050083A1/ja not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0667148A1 (en) * | 1992-11-06 | 1995-08-16 | Hisamitsu Pharmaceutical Co., Inc. | Peroral pharmaceutical preparation releasable in lower digestive tract |
WO1998005310A1 (fr) * | 1996-08-02 | 1998-02-12 | Hisamitsu Pharmaceutical Co., Inc. | Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale |
Non-Patent Citations (1)
Title |
---|
See also references of EP1155701A4 * |
Also Published As
Publication number | Publication date |
---|---|
JP2000247911A (ja) | 2000-09-12 |
US6620788B1 (en) | 2003-09-16 |
CA2364780A1 (en) | 2000-08-31 |
AU2692200A (en) | 2000-09-14 |
EP1155701A4 (en) | 2002-10-23 |
EP1155701A1 (en) | 2001-11-21 |
TWI232754B (en) | 2005-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2234011T3 (es) | Productos farmaceuticos de peptidos de administracion oral. | |
US7820722B2 (en) | Permeation enhancers | |
CA2045472C (en) | Drug delivery compositions | |
US5744166A (en) | Drug delivery compositions | |
WO1998005310A1 (fr) | Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale | |
KR100863146B1 (ko) | 경구 흡수 개선 의약 조성물 | |
JP2002537343A (ja) | 多重粒子製剤 | |
EP0753311A1 (en) | Microemulsion preparation containing difficultly absorbable substance | |
WO2000050083A1 (fr) | Agents facilitant l'absorption enterale | |
JPH04225922A (ja) | 大腸崩壊性ポリペプチド系経口製剤 | |
US20080241260A1 (en) | Compositions for Enhanced Absorption of Biologically Active Agents | |
JPH1095738A (ja) | 経粘膜吸収製剤用組成物 | |
JP2012111773A (ja) | 経口吸収改善用医薬組成物 | |
TW200410729A (en) | Multilayered delivery system and method for producing the same | |
JPH10152431A (ja) | 経口製剤用カプセルと経口カプセル製剤 | |
JP3009911B2 (ja) | ペプチド又は蛋白の内服用新規製剤 | |
WO2000024424A1 (fr) | Agents favorisant l'absorption a travers la muqueuse renfermant un acide gras insature et un gel polymere, medicaments les contenant | |
JP3597233B2 (ja) | 経鼻組成物及びそれを含有する経鼻製剤 | |
EP4292583A1 (en) | Composition in which absorbability of poorly-absorbable drug is improved | |
JP2000281589A (ja) | 経粘膜吸収助剤 | |
WO2006072613A2 (fr) | Préparation contenant des microparticules d'une résine polysaccharidique insoluble portant un principe actif biopolymérique, ainsi que son procédé de fabrication | |
WO2001064253A1 (fr) | Compositions medicinales renfermant un agent modificateur de la glycoproteine p pour administration au gros intestin | |
AU7234800A (en) | Oral peptide pharmaceutical products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN ID JP KR US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2364780 Country of ref document: CA Ref country code: CA Ref document number: 2364780 Kind code of ref document: A Format of ref document f/p: F Ref country code: JP Ref document number: 2000 600693 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000905337 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000905337 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09913761 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000905337 Country of ref document: EP |